BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28603096)

  • 1. Patients with early recurrence of hepatocellular carcinoma have poor prognosis.
    Kobayashi T; Aikata H; Kobayashi T; Ohdan H; Arihiro K; Chayama K
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):279-288. PubMed ID: 28603096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A.
    Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
    Hepatogastroenterology; 2015; 62(137):164-8. PubMed ID: 25911889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.
    Zhao WC; Zhang HB; Yang N; Fu Y; Qian W; Chen BD; Fan LF; Yang GS
    World J Gastroenterol; 2012 Jul; 18(25):3272-81. PubMed ID: 22783052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
    Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
    Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection.
    Saito R; Amemiya H; Hosomura N; Kawaida H; Maruyama S; Shimizu H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2019 Jun; 39(6):3033-3038. PubMed ID: 31177145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Zhang ZY; Zhou ZQ; Zhou GW
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.
    Valenzuela A; Ha NB; Gallo A; Bonham C; Ahmed A; Melcher M; Kim LH; Esquivel C; Concepcion W; Ayoub WS; Lutchman GA; Daugherty T; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):158-64. PubMed ID: 24804988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recurrence in large hepatocellular carcinoma after curative hepatic resection: prognostic significance and risk factors.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Oct; 61(135):2035-41. PubMed ID: 25713907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients.
    Du ZG; Wei YG; Chen KF; Li B
    Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):153-61. PubMed ID: 24686542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.